Drug General Information
Drug ID
D08DGW
Former ID
DNCL003364
Drug Name
CXL
Drug Type
Small molecular drug
Indication Methicillin-resistant staphylococcus aureus infection [ICD10:B95.62] Phase 2 [550289]
Company
AstraZeneca
Structure
Download
2D MOL

3D MOL

Formula
C6H12O
Canonical SMILES
C1CCC(CC1)O
InChI
1S/C6H12O/c7-6-4-2-1-3-5-6/h6-7H,1-5H2
InChIKey
HPXRVTGHNJAIIH-UHFFFAOYSA-N
PubChem Compound ID
PubChem Substance ID
Target and Pathway
Target(s) Beta-lactamase Target Info Modulator [551120]
References
Ref 550289Clinical pipeline report, company report or official report of AstraZeneca.
Ref 551120Beta-Lactam Antibiotics Renaissance. Antibiotics. 2014, 3(2), 193-215.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.